Home

agitation pair mosaic puma biotechnology news helper Ocean Involved

Can Puma Biotechnology Inc (PBYI) Stock Rise to the Top of Healthcare  Sector Tuesday?
Can Puma Biotechnology Inc (PBYI) Stock Rise to the Top of Healthcare Sector Tuesday?

Puma Biotechnology Presents Final Results from the Biliary Tract Cohort of  the Phase 2 SUMMIT 'Basket' Trial of Neratinib at the ASCO 2022 Annual  Meeting | Business Wire
Puma Biotechnology Presents Final Results from the Biliary Tract Cohort of the Phase 2 SUMMIT 'Basket' Trial of Neratinib at the ASCO 2022 Annual Meeting | Business Wire

Conspiracy Theory: Did Puma Biotech Exec Resign Because of Bad News Ahead?  | BioSpace
Conspiracy Theory: Did Puma Biotech Exec Resign Because of Bad News Ahead? | BioSpace

Puma Biotechnology Surging
Puma Biotechnology Surging

Should You Buy Puma Biotechnology Inc (PBYI) Stock Tuesday?
Should You Buy Puma Biotechnology Inc (PBYI) Stock Tuesday?

The Prognosis For Puma Biotechnology (NASDAQ:PBYI) | Seeking Alpha
The Prognosis For Puma Biotechnology (NASDAQ:PBYI) | Seeking Alpha

Former Puma Biotech executive gets U.S. prison term for insider trading |  Reuters.com
Former Puma Biotech executive gets U.S. prison term for insider trading | Reuters.com

Puma Biotechnology falls more than 20%
Puma Biotechnology falls more than 20%

Puma Biotechnology Announces Publication of Phase II Clinical Trial of  Alisertib in JAMA Oncology | Business Wire
Puma Biotechnology Announces Publication of Phase II Clinical Trial of Alisertib in JAMA Oncology | Business Wire

Here's Why Puma Biotechnology Fell 17.2% in April | The Motley Fool
Here's Why Puma Biotechnology Fell 17.2% in April | The Motley Fool

Puma Biotechnology (PBYI) Stock Climbs On Orphan Drug Designation | Alpha  Stock News
Puma Biotechnology (PBYI) Stock Climbs On Orphan Drug Designation | Alpha Stock News

Puma shares nearly triple on drug news, but options smell 'fishy'
Puma shares nearly triple on drug news, but options smell 'fishy'

Puma Biotechnology Secures $125 Million Note Purchase by Athyrium Capital |  Business Wire
Puma Biotechnology Secures $125 Million Note Purchase by Athyrium Capital | Business Wire

Puma Biotechnology Reports Results of PB272 (neratinib) in P-III NALA Trial  for Patients with 2L+ HER2+ Metastatic Breast Cancer #ASCO2019
Puma Biotechnology Reports Results of PB272 (neratinib) in P-III NALA Trial for Patients with 2L+ HER2+ Metastatic Breast Cancer #ASCO2019

Puma Biotechnology Secures $125 Million Note Purchase by Athyrium Capital |  Business Wire
Puma Biotechnology Secures $125 Million Note Purchase by Athyrium Capital | Business Wire

Puma Biotechnology
Puma Biotechnology

Is Puma off the cancer M&A list? With Nerlyx marketing deal, some investors  think so | Fierce Pharma
Is Puma off the cancer M&A list? With Nerlyx marketing deal, some investors think so | Fierce Pharma

Puma Biotechnology Executives Under Investigation for Breast Cancer Drug —  Schubert Jonckheer & Kolbe
Puma Biotechnology Executives Under Investigation for Breast Cancer Drug — Schubert Jonckheer & Kolbe

Puma (PBYI): Recent Rally Looks Overdone, Unsupported With Fundamentals |  Seeking Alpha
Puma (PBYI): Recent Rally Looks Overdone, Unsupported With Fundamentals | Seeking Alpha

PumaBiotech (@pumabiotech) / Twitter
PumaBiotech (@pumabiotech) / Twitter

Puma Biotechnology | $PBYI Stock | Shares Climb Up as Company Announced FDA  Approval for NERLYNX - Warrior Trading News
Puma Biotechnology | $PBYI Stock | Shares Climb Up as Company Announced FDA Approval for NERLYNX - Warrior Trading News

Puma Biotechnology up 15% after quarterly earnings beats (NASDAQ:PBYI) |  Seeking Alpha
Puma Biotechnology up 15% after quarterly earnings beats (NASDAQ:PBYI) | Seeking Alpha

Puma Biotechnology - Updates, News, Events, Signals & Triggers
Puma Biotechnology - Updates, News, Events, Signals & Triggers

Puma Biotechnology - Updates, News, Events, Signals & Triggers
Puma Biotechnology - Updates, News, Events, Signals & Triggers

Goldman Sachs Group Cuts Stake in Puma Biotechnology (PBYI)
Goldman Sachs Group Cuts Stake in Puma Biotechnology (PBYI)

Why Puma Biotechnology (PBYI) Stock Is Surging Today - TheStreet
Why Puma Biotechnology (PBYI) Stock Is Surging Today - TheStreet

Puma Biotechnology (Nasdaq:PBYI) - Stock Price, News & Analysis - Simply  Wall St
Puma Biotechnology (Nasdaq:PBYI) - Stock Price, News & Analysis - Simply Wall St